{"id":955574,"date":"2026-04-28T16:11:13","date_gmt":"2026-04-28T20:11:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/"},"modified":"2026-04-28T16:11:13","modified_gmt":"2026-04-28T20:11:13","slug":"myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/","title":{"rendered":"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SALT LAKE CITY, April  28, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=liN-f9eAtU2o5GVaTFb_zE17qvp8yHP9XVcC72LpOOZYFTItppHz-IXT5Uq4_mkpJAu_0SJQlyH5TW_JPyKkrwHy91nRntGSpYMsD8nCCfQ=\" rel=\"nofollow\" target=\"_blank\">Myriad Genetics, Inc.<\/a>, (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2026 earnings conference call at 4:30 pm ET on Tuesday, May 5, 2026. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the first quarter of 2026.<\/p>\n<p>A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wE5MHrR1W5uaP_BcBP5-TbvmZxqn4gWiR41VAC83JuI0zmA_ktqC7aMAGXyFaKEfQ0aIiYcrG0EoZBUSVA7sKg_xwkIjfJ2lHq_7Q2jkhfrZzFcXzXQRsTFOTab-rqlJLpTe3CoVvXMF8me3Y6XUrov1vzWiuTSeqbqpvFr0kNWrIolUXIIrZkocXROWmpeafKmJBxP4pzAfG6pZy_KD6CeAd-1D7QM-olcTF5jnEbhUfQIegQFedj3P6aCkrzCxzW_Za_cr6Q-rnHCm-UQ4IA==\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a>. To participate in the live conference call via telephone, please register <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=er3v5zj3wZRLZF4x5Rhs3XL0vvxPXoxgXjwUA1awDoyE83msMWJVgr-wWfxD8Q5A8okZ2f9aXuIsthhcJrAsFLLEp-_N30s5Lnc6gZ9BqwDtQrY_9VzIb5IypIUOKsjQ5E9iNA3Mcz_z2QvERyQO9xA47xGzZB-mbsiMlMvgL7c=\" rel=\"nofollow\" target=\"_blank\">here<\/a>. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wE5MHrR1W5uaP_BcBP5-TV-IsqKiIWm7W0i52Np0HJs2F5VS2GJhQTVxDdfyEfDVqLunGZx2zZha8twBZ7BjGB0FP8NYcgM0pRSphHbrztN27ZpbXsK0LffYvqbRtowkYUmYkvufGhTAgU9VfU2P3--j-1JDobCP_seuPKZ7ekbpWTPLDkahx2augoHbl1O1D6SDv4uh9w5W9yZSjyA4VbJeVAkWWvC8BU3s0rawL4WVDgCMGkUt92-Ko-aczduiG1n4ENBAgmXiulGG1rleJw==\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a>\u00a0following the call.<\/p>\n<p><strong>About Myriad Genetics\u00a0<\/strong><br \/>Myriad Genetics is a leading molecular diagnostic and precision medicine company committed to advancing health and well-being for all. Myriad Genetics develops and commercializes molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more precise treatment and contribute to lowering healthcare costs. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fIyELIo9cU_5rpp7323V3VBfZZrxTYaRkX-XBICKMxJ35X4hSxFUtibVaQZRmDWP0RA_-QZ4J5riJs4p6flO2g==\" rel=\"nofollow\" target=\"_blank\">myriad.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong>\u00a0<br \/>Matt Scalo\u00a0<br \/>(801) 584-3532\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=29lrbpVDLOoB8KZnvILq-FHv_T3p5tFKVcckcPPS9ARvFydD5_u9OoTObknXk_oHgUpxxPpGrMdyRl57vzDvFg==\" rel=\"nofollow\" target=\"_blank\"><u>IR@myriad.com<\/u><\/a>\u00a0<\/p>\n<p>\n        <strong>Media Contact<\/strong>\u00a0<br \/>Kate Schraml<br \/>(224) 875-4493<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f1bVN_MUN5FVzPfl0pEUOnJFBnwxebGwUgsp5K5XkjtPli2lqVdNPO4qTchOYqTX_Xe89PppEVRAqRXPunngAQ==\" rel=\"nofollow\" target=\"_blank\"><u>PR@myriad.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzA2NTBiMGMtYmYyZi00OTVlLWJjMTgtNmExY2I3MWUyM2VkLTEwMTk0NjAtMjAyNi0wNC0yOC1lbg==\/tiny\/Myriad-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SALT LAKE CITY, April 28, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2026 earnings conference call at 4:30 pm ET on Tuesday, May 5, 2026. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the first quarter of 2026. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at\u00a0investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-955574","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SALT LAKE CITY, April 28, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2026 earnings conference call at 4:30 pm ET on Tuesday, May 5, 2026. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the first quarter of 2026. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at\u00a0investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the &hellip; Continue reading &quot;Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-28T20:11:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026\",\"datePublished\":\"2026-04-28T20:11:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/\"},\"wordCount\":245,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/\",\"name\":\"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=\",\"datePublished\":\"2026-04-28T20:11:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/","og_locale":"en_US","og_type":"article","og_title":"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk","og_description":"SALT LAKE CITY, April 28, 2026 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2026 earnings conference call at 4:30 pm ET on Tuesday, May 5, 2026. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the first quarter of 2026. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at\u00a0investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the &hellip; Continue reading \"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-28T20:11:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026","datePublished":"2026-04-28T20:11:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/"},"wordCount":245,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/","name":"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=","datePublished":"2026-04-28T20:11:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzY5MCM3NTY4MDI2IzIwMDc4ODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/955574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=955574"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/955574\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=955574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=955574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=955574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}